ZC
Ziff Capital Partners
Activity from announced rounds
Activity in this selectionUndisclosed
Ziff Capital Partners is the firm named in Stellular and ai3Bio coverage, with ai3Bio identifying it as founding investor and co-lead.
Recorded funding activity
Stellular develops biologics for ocular disease. Ai3Bio develops therapies targeting Th17 immune cells. The pending relationship stays in draft while the firm’s event-specific roles are preserved.
- Rounds participated in
- 0
- Confirmed lead rounds
- — All roles disclosed
- New companies
- 0 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share
By stage
No activity in this selection.
By primary sector
No activity in this selection.
By country
No activity in this selection.
Rounds
0 in this selectionNo rounds match this selection.